May - 2014
| Previous Next | Showing Journal 11 of 15 |
A Randomized, Double-Blind, Placebo-Controlled Dose Range Study of Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal*Scott W. Mueller, Candice R. Preslaski, Tyree H. Kiser, et al Crit Care Med, 2014, 42 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
No Comments yet.
Comment
"Approximately 10-33% of ICU patients have an alcohol use disorder (AUD), and are at risk for developing alcohol withdrawal syndrome (AWS)”. This study examines the difference between the traditional use of benzodiazepines to treat this and dexmedetomidine (DEX) in a...